NCT02141581View on ClinicalTrials.gov

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

PHASE4CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Influenza
Interventions
BIOLOGICAL

Fluzone® (IM)

This vaccine is given intramuscularly (IM)

BIOLOGICAL

Fluzone® Intradermal (ID)

This vaccine is given intradermally (ID)

BIOLOGICAL

2011-2012 FluMist®

This vaccine is given intranasally

Trial Locations (1)

94305

Stanford LPCH Vaccine Program, Stanford

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Stanford University

OTHER

NCT02141581 - Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) | Biotech Hunter | Biotech Hunter